(41S,12S,13aS)-methyl 13a-ethyl-12-hydroxy-2,3,41,5,6,12,13,13a-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate; (3?,14?,16?)-14,15-Dihydro-14-hydroxy-eburnamenine-14-carboxylic Acid Methyl Ester; Minorine; 1H-Indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine Eburnamenine-14-carboxylic acid deriv.; (+)-Vincamine; (+)-cis-Vincamine; Angiopac; Arteriovinca; Devincan; Devinkan; Equipur; Methyl vincaminate; Minorin; NSC 91998; Novicet; Ocu-vinc; Oxybral; Oxygeron; Perval; Pervincamine; Pervone; Sostenil; Tripervan; Vincadar; Vincafarm; Vincafolina; Vincafor; Vincagil; Vincalen; Vincamidol; Vincamin; Vincapan; Vincapront; Vincimax; Vinodrel Retard; Vinvasaunier; Vraap; cis-Vincamine
Vincamine is a fully characterized chemical compound used as a reference standard of API Vincamine. The standard offered is compliant with regulatory guidelines. Vincamine is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 1617-90-9
